Immunomodulatory gene therapy for haematological malignancies

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.

Cancer immunology, immunotherapy : CII·2020

Cross-sectional increase of adherence to multidisciplinary tumor board decisions.

BMC cancer·2018

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.

Leukemia·2015

[State of the art treatment of progressive or refractory multiple myeloma].

Deutsche medizinische Wochenschrift (1946)·2014

Hairy cell leukemia: short review, today's recommendations and outlook.

Blood cancer journal·2014

Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.

Leukemia research and treatment·2012

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

British journal of haematology·2026

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

British journal of haematology·2026

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

British journal of haematology·2026

Design of a modified platelet immunofluorescence test to assess platelet-reactive antibody burden and its association with platelet functional exhaustion and clinical features in chronic immune thrombocytopenia.

British journal of haematology·2026

Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany-A prospective, multicentre trial.

British journal of haematology·2026

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

British journal of haematology·2026

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Cancer immunology research·2026

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Inflammatory intestinal diseases·2026

Related Experiment Videos

Immunomodulatory gene therapy for haematological malignancies

Related Concept Videos

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.

Cross-sectional increase of adherence to multidisciplinary tumor board decisions.

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.

[State of the art treatment of progressive or refractory multiple myeloma].

Hairy cell leukemia: short review, today's recommendations and outlook.

Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

Design of a modified platelet immunofluorescence test to assess platelet-reactive antibody burden and its association with platelet functional exhaustion and clinical features in chronic immune thrombocytopenia.

Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany-A prospective, multicentre trial.

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Related Experiment Videos

Immunomodulatory gene therapy for haematological malignancies

Related Concept Videos

Related Articles